Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Wright

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Cancers|June 18, 2020
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient SurvivalDonald Freudenstein, Cassandra Litchfield, Franco Caramia, et al.
Asian Cardiovascular & Thoracic Annals|April 15, 2021
Pulmonary carcinoid tumours: A multi-centre analysis of survival and predictors of outcome following sublobar, lobar, and extended pulmonary resectionsSameer Thakur, Daniel Florisson, Stacy Telianidis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2021
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort studyTiffany Lin, Jonathan Pham, Eldho Paul, et al.
Pathology|December 4, 2016
Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimensVivek Rathi, Gavin Wright, Diana Constantin, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated CirrhosisGautam Mehta, Sam Rousell, Gary Burgess, et al.
The New England Journal of Medicine|March 3, 2021
A Randomized Trial of Albumin Infusions in Hospitalized Patients with CirrhosisLouise China, Nick Freemantle, Ewan Forrest, et al.
Hepatology (Baltimore, Md.)|May 14, 2009
L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic ratsNathan A Davies, Gavin Wright, Lars M Ytrebø, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic RadiotherapyShankar Siva, Brent Chesson, Jason W Callahan, et al.
Journal of Hepatology|May 11, 2010
Role of aquaporin-4 in the development of brain oedema in liver failureGavin Wright, Robin Soper, Heather F Brooks, et al.
Scientific Reports|October 30, 2020
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancerJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Cancers|June 18, 2020
TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient SurvivalDonald Freudenstein, Cassandra Litchfield, Franco Caramia, et al.
Asian Cardiovascular & Thoracic Annals|April 15, 2021
Pulmonary carcinoid tumours: A multi-centre analysis of survival and predictors of outcome following sublobar, lobar, and extended pulmonary resectionsSameer Thakur, Daniel Florisson, Stacy Telianidis, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2021
Impacts of lung cancer multidisciplinary meeting presentation: Drivers and outcomes from a population registry retrospective cohort studyTiffany Lin, Jonathan Pham, Eldho Paul, et al.
Pathology|December 4, 2016
Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimensVivek Rathi, Gavin Wright, Diana Constantin, et al.
Journal of Clinical and Experimental Hepatology|October 11, 2018
A Placebo-Controlled, Multicenter, Double-Blind, Phase 2 Randomized Trial of the Pan-Caspase Inhibitor Emricasan in Patients with Acutely Decompensated CirrhosisGautam Mehta, Sam Rousell, Gary Burgess, et al.
The New England Journal of Medicine|March 3, 2021
A Randomized Trial of Albumin Infusions in Hospitalized Patients with CirrhosisLouise China, Nick Freemantle, Ewan Forrest, et al.
Hepatology (Baltimore, Md.)|May 14, 2009
L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic ratsNathan A Davies, Gavin Wright, Lars M Ytrebø, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 3, 2015
Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic RadiotherapyShankar Siva, Brent Chesson, Jason W Callahan, et al.
Journal of Hepatology|May 11, 2010
Role of aquaporin-4 in the development of brain oedema in liver failureGavin Wright, Robin Soper, Heather F Brooks, et al.
Scientific Reports|October 30, 2020
SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancerJoshua T Burgess, Emma Bolderson, Mark N Adams, et al.
Pageof 12